⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MLYS News

Mineralys Therapeutics, Inc. Common Stock

Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension